Recombinant human PDGF-BB in foot and ankle fusion Journal Article

Local Library Link: Find It @ Loyola

Authors: DiGiovanni, C. W.; Lin, S; Pinzur, M
Article Title: Recombinant human PDGF-BB in foot and ankle fusion
Abstract: Autogenous bone graft (autograft) is currently the gold standard for augmenting bone repair and fusion procedures of the foot and ankle. The time, cost and morbidity involved in obtaining autograft, however, are well documented and legitimate concerns remain surrounding this intervention. Endogenous human PDGF is chemotactic and mitogenic for osteoblasts and undifferentiated osteoprogenitor cells, and upregulates expression of cytokines necessary for osseous and soft tissue healing and regeneration. The BB isoform of PDGF, and the biosynthetic replica recombinant human PDGF-BB, is a key regulatory molecule in bone homeostasis, repair and regeneration. When combined with a beta-tricalcium phosphate osteoconductive matrix, recombinant human PDGF-BB mitigates a number of problems associated with the use of autograft and, based on its preclinical performance and early clinical success, appears to be an equally effective and perhaps an even safer alternative to autograft for foot and ankle fusion (arthrodesis) procedures.
Journal Title: Expert review of medical devices
Volume: 9
Issue: 2
ISSN: 1745-2422; 1743-4440
Publisher: Unknown  
Journal Place: England
Date Published: 2012
Start Page: 111
End Page: 122
Language: eng
DOI/URL:

10.1586/erd.11.76
Notes: JID: 101230445; 0 (Calcium Phosphates); 0 (Proto-Oncogene Proteins c-sis); 0 (Recombinant Proteins); 0 (beta-tricalcium phosphate); 0 (platelet-derived growth factor BB); ppublish